Determination of berberine in human plasma by liquid chromatography-electrospray ionization-mass spectrometry

Journal of Pharmaceutical and Biomedical Analysis

Volumn 44, Issue 4, 2007, Pages 931-937

  Hua, Wenyan ^a   Ding, Li ^a   Chen, Yan ^a   Gong, Bin ^a   He, Jianchang ^b   Xu, Guili ^b  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b KUNMING GENERAL HOSPITAL   (China)

Author keywords

Berberine; LC ESI MS; Pharmacokinetics

Indexed keywords

BENZYL DERIVATIVE; BERBERINE;

ARTICLE; BLOOD SAMPLING; DRUG BLOOD LEVEL; ELECTROSPRAY MASS SPECTROMETRY; ELUTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; ION MONITORING; LIQUID CHROMATOGRAPHY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; STANDARD; VALIDATION PROCESS;

BERBERINE; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, LIQUID; FREEZING; HUMANS; INDICATORS AND REAGENTS; QUALITY CONTROL; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SOLUTIONS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 34447640334     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2007.03.022     Document Type: Article

References (23)

1. Birdsall T., and Kelly G. Altern. Med. Rev. 2 (1997) 94-103
2. Zhao X., and Guo X. Zhong Hua Xin Xue Guan Bing Za Zhi 17 (1989) 159-161
3. Chi L., Chin W., and Tsung Y. Cancer Lett. 203 (2004) 127-137
4. Mitani N., Murakami K., Yamaura T., Ikeda T., and Saiki I. Cancer Lett. 165 (2001) 35-42
5. Marinova E., Nikolova D., Popova D., Gallacher G., and Ivanovska N. Immunopharmacology 48 (2000) 9-16
6. Ko W., Yao X., Lau C., Law W., Chen Z., Kwok W., Ho K., and Huang Y. Eur. J. Pharmacol. 399 (2000) 187-196
7. Rojsanga P., Gritsanapan W., and Suntornsuk L. Med. Princ. Pract. 15 (2006) 373-378
8. Liu Q., Liu Y., Li Y., and Yao S. J. Sep. Sci. 29 (2006) 1268-1274
9. Chen Y., Wen K., and Her G. J. Chromatogr. A 866 (2000) 273-280
10. Keiichi S., Shinichi K., and Yuji I. J. Chromatogr. A 786 (1997) 371-376
11. Z. Shen, M. Xie, Y. Xue, B. Xue, 28 (1993) 532-526.
12. Chen C., and Chang H. J. Chromatogr. B Biomed. Appl. 665 (1995) 117-123
13. Tsai P., and Tsai T. J. Chromatogr. A 961 (2002) 125-130
14. Shen M., Sun Q., and Wang H. Chin. Pharmacol. Bull. 99 (1993) 64-67
15. Lu T., Liang Y., Song J., Xie L., Wang G., and Liu X. J. Pharm. Biomed. Anal. 40 (2006) 1218-1224
16. Zuo F., Nakamura N., Akao T., and Hattori M. Drug Metab. Dispos. 34 (2006) 2064-2072
17. Miyazaki H., Shirai E., Ishibashi M., and Niizima K. J. Chromatogr. 152 (1978) 79-86
18. Yu C., Zhang H., Pan J., Hong Y., Ren J., Zhu D., and Xu X. Chin. J. Chin. Pharmacol. 16 (2000) 36-39
19. Ding L., Huang X., Yang J., Bian X., Zhang Z., and Liu G. J. Pharm. Biomed. Anal. 40 (2006) 758-762
20. Ding L., Yang L., Liu F., Ju W., and Xiong N. J. Pharm. Biomed. Anal. 42 (2006) 213-217
21. Ding L., Li L., and Ma P. J. Pharm. Biomed. Anal. 43 (2007) 575-579
22. Zhao L., Ding L., and Wei X. J. Pharm. Biomed. Anal. 40 (2006) 95-99
23. Guidance for Industry, Bioanalytical Method Validation, US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), May 2001.